Side Effects Lenacapavir Phase 3 Trial Obstructive Sleep Apnea Late-Stage Clinical Trial Dose Optimization Efficacy Obesity Weight Loss Medicine Field Roche CT-996 Investigational Drugs GLP-1 Medications Lecanemab Wegovy Regulatory Approval Lung Cancer Liraglutide Tirzepatide PURPOSE 2 Study Bristol Myers Squibb Cobenfy Anti-Obesity Drugs Eli Lilly and Company Disease-Modifying Therapies Patient Safety Alzheimer's Disease Regulatory Approvals Intra-Cellular Therapies GSK Benefits Obesity Treatment Liver Disease Treatment Competition in Obesity Market Obesity Treatments Phase I Trial Phase II Trial Neurological Conditions Drug Withdrawal Felzartamab FDA Approval Market Clearance